Skip to main content
BRISTOL MYERS SQUIBB CO logo

BRISTOL MYERS SQUIBB CO — Investor Relations & Filings

Ticker · BMY ISIN · US1101222073 LEI · HLYYNH7UQUORYSJQCN42 US Manufacturing
Open in API
Filings indexed 3,441 across all filing types
Latest filing 2026-06-05 Audit Report / Informat…
Country US United States of America
Listing US BMY

About BRISTOL MYERS SQUIBB CO

https://www.bms.com

Bristol Myers Squibb is a global biopharmaceutical company engaged in the discovery, development, licensing, manufacturing, and commercialization of innovative medicines. The company focuses on addressing serious diseases with significant unmet medical needs, with core therapeutic areas in oncology, immunology, and cardiovascular disease. Its operations encompass the entire product lifecycle, from scientific research and clinical trials to the global distribution and sale of its biopharmaceutical products. The company's mission is to help patients prevail over serious diseases through scientific innovation.

Recent filings

Filing Released Lang Actions
FORM 11-K
Audit Report / Information Classification · 85% confidence The document is a Form 11-K “Annual Report pursuant to Section 15(d) of the Securities Exchange Act of 1934” for the Bristol-Myers Squibb Puerto Rico, Inc. Savings and Investment Program. It is a standalone SEC filing containing the Report of Independent Registered Public Accounting Firm and full audited financial statements (Statements of Net Assets and Changes, Notes, Supplemental Schedules). This matches our definition for a standalone audit report/information filing (excluding a full corporate 10-K). Therefore this is classified as Audit Report / Information (AR). FY 2025
2026-06-05 English
FORM 11-K
Regulatory Filings Classification · 85% confidence The document is an SEC Form 11-K – an annual report for an employee benefit plan (Employee Incentive Thrift Plan) including audited financial statements and schedules. It is not a corporate 10-K, nor does it match other specific categories such as proxy, dividend, management change, or interim report. Since there's no separate category defined for Form 11-K filings, it falls into the general SEC compliance/regulatory filings category: RNS.
2026-06-05 English
FORM 11-K
Annual Report Classification · 80% confidence The document is an SEC Form 11-K “Annual Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934” for the fiscal year ended December 31, 2025. It contains the full financial statements of the Bristol-Myers Squibb Company Savings and Investment Program, complete with audited net asset statements, changes in net assets, notes and supplemental schedules. This is a substantive annual report filing with detailed financials (not merely an announcement or certification), so it best fits the Annual Report category. In our taxonomy, the Annual Report category (10-K) covers official yearly reports with full financial performance information. FY 2025
2026-06-05 English
S-8 - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)
Regulatory Filings Classification · 73% confidence The document is a SEC registration statement on Form S-8, filed under the Securities Act of 1933 to register shares for an employee stock award plan. It is not an annual report (10-K), earnings release, proxy, merger, or any other specific category in our taxonomy. Form S-8 is a regulatory filing for share registration and therefore falls under the catch-all “Regulatory Filings” category (RNS).
2026-05-08 English
8-K - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)
Declaration of Voting Results & Voting Rights Announcements Classification · 97% confidence The document is a Form 8-K current report (filed under the Securities Exchange Act) and specifically Item 5.07, which details the results of shareholder votes at the company’s Annual Meeting. It provides vote tallies for director elections, executive compensation approval, stock plan approval, auditor ratification, and a shareholder proposal. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA).
2026-05-08 English
10-Q - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)
Interim / Quarterly Report Q1 2026
2026-04-30 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.